HopeStage
Back to all studies
RecruitingNCT06898788

A probiotic and brain and gut measures in young people with depression

About this titleRead the official source — NCT06898788
Medication studyAges 15–24United States
The study in practice

Understand this study

Who could participate?

Listed age limits: 15 years to 24 years.

Listed locations
San FranciscoSee all locations and recruitment
Study phase
Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.

Get this study by email

HopeStage may email me about this study.
Loading the security check...

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: May 15, 2025
Recruitment status
Recruiting
Enrollment listed in the registry
77
Sponsor
University of California, San Francisco
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
Locations
United States
Age range
From 15 Years to 24 Years
Official registry ID
NCT06898788
Official title
Show the full official title

Probiotic Administration for Adolescent Depression

Recruitment & locations

Currently recruiting

San Francisco

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is University of California, San Francisco, a university.

Does this study involve medication?

Yes. The study involves medication, including Visbiome and Placebo.

Who can participate?

Listed age limits: 15 years to 24 years.

Is this study still recruiting?

The registry lists this study as recruiting.

Want to explore more studies?

Explore studies